Investigational Drug Information for Tauroursodeoxycholic acid
✉ Email this page to a colleague
What is the development status for investigational drug Tauroursodeoxycholic acid?
Tauroursodeoxycholic acid is an investigational drug.
There have been 23 clinical trials for Tauroursodeoxycholic acid.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2012.
The most common disease conditions in clinical trials are Sclerosis, Motor Neuron Disease, and Amyotrophic Lateral Sclerosis. The leading clinical trial sponsors are Washington University School of Medicine, University of Dublin, Trinity College, and University of Sheffield.
Summary for Tauroursodeoxycholic acid
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,396 |
| WIPO Patent Applications | 548 |
| Japanese Patent Applications | 211 |
| Clinical Trial Progress | Phase 3 (2012-12-01) |
| Vendors | 50 |
Recent Clinical Trials for Tauroursodeoxycholic acid
| Title | Sponsor | Phase |
|---|---|---|
| Open Label Extension of TUDCA-ALS Study | Bruschettini S.r.l. | Phase 3 |
| Open Label Extension of TUDCA-ALS Study | Istituto Superiore di Sanità | Phase 3 |
| Open Label Extension of TUDCA-ALS Study | KU Leuven | Phase 3 |
Clinical Trial Summary for Tauroursodeoxycholic acid
Top disease conditions for Tauroursodeoxycholic acid
Top clinical trial sponsors for Tauroursodeoxycholic acid
US Patents for Tauroursodeoxycholic acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
